Suchergebnisse - "Tjan, Lidya Handayani"

PubPharm (27)

1

Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines’ efficacy

enthalten in: bioRxiv.org | 2024

von Ren, Z. | Nishimura, M. | Tjan, L. | +15

2

The roseoloviruses downregulate the protein tyrosine phosphatase PTPRC (CD45)

enthalten in: bioRxiv.org | 2023

von Whyte, M. | Smith, K. | Buchberger, A. | +5

3

Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants

enthalten in: Journal of virology | 2023

von Ishimaru, H. | Nishimura, M. | Tjan, L. | +18

4

Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines : a case report

enthalten in: European heart journal. Case reports | 2023

von Fujii, M. | Toba, T. | Fukuyama, Y. | +3

5

Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021

enthalten in: bioRxiv.org | 2023

von Ren, Z. | Furukawa, K. | Nishimura, M. | +15

6

The combination of isomalto-oligosaccharides (IMO)-based dietary fiber and hypocaloric high-protein diet could improve the anthropometric profile and fasting plasma glucose of healthy adults : A repeated single-arm clinical trial

enthalten in: Contemporary clinical trials communications | 2022

von Wijaya, H. | Hirata, Y. | Tjan, L. | +8

7

The Trend of Neutralizing Antibody Response Against SARS-CoV-2 and the Cytokine/Chemokine Release in Patients with Differing Severities of COVID-19: All Individuals Infected with SARS-CoV-2 Obtained Neutralizing Antibody

enthalten in: bioRxiv.org | 2022

von Tjan, L. | Nagano, T. | Furukawa, K. | +6

8

Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination

enthalten in: The Journal of infectious diseases | 2022

von Tjan, L. | Furukawa, K. | Kurahashi, Y. | +4

CommentOn: J Infect Dis. 2022 Oct 17;226(8):1372-1381. - PMID 35267040

9

Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination

enthalten in: The Journal of infectious diseases | 2022

von Kurahashi, Y. | Furukawa, K. | Sutandhio, S. | +13

10

Novel monoclonal antibodies showing broad neutralizing activity for SARS-CoV-2 variants including Omicrons BA.5 and BA.2.75

enthalten in: bioRxiv.org | 2022

von Ishimaru, H. | Nishimura, M. | Tjan, L. | +17